Literature DB >> 8951443

Intravascularly applied K(+)-channel blockers suppress differently the positive endocochlear potential maintained by vascular perfusion.

S Takeuchi1, A Kakigi, T Takeda, H Saito, A Irimajiri.   

Abstract

We studied the effects of several K+ channel blockers on the positive endocochlear potential (EP) of guinea pigs undergoing perfusion via the anterior inferior cerebellar artery. The EP level was reversibly suppressed by 50-60% in the presence of Ba2+ (2 mM), quinine (2 mM) or verapamil (1 mM) in the perfusate, but not significantly affected by tetraethylammonium (20 mM) or 4-aminopyridine (5 mM). Although the effective site(s) of these blockers at the cell level has not been located yet, these findings indicate an important role for a K+ conductance in the generation of the EP.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8951443     DOI: 10.1016/s0378-5955(96)00151-7

Source DB:  PubMed          Journal:  Hear Res        ISSN: 0378-5955            Impact factor:   3.208


  4 in total

1.  Mechanism generating endocochlear potential: role played by intermediate cells in stria vascularis.

Authors:  S Takeuchi; M Ando; A Kakigi
Journal:  Biophys J       Date:  2000-11       Impact factor: 4.033

Review 2.  The role of an inwardly rectifying K(+) channel (Kir4.1) in the inner ear and hearing loss.

Authors:  J Chen; H-B Zhao
Journal:  Neuroscience       Date:  2014-01-28       Impact factor: 3.590

3.  Mutations of KCNJ10 together with mutations of SLC26A4 cause digenic nonsyndromic hearing loss associated with enlarged vestibular aqueduct syndrome.

Authors:  Tao Yang; Jose G Gurrola; Hao Wu; Sui M Chiu; Philine Wangemann; Peter M Snyder; Richard J H Smith
Journal:  Am J Hum Genet       Date:  2009-05-07       Impact factor: 11.025

4.  Hearing Loss Controlled by Optogenetic Stimulation of Nonexcitable Nonglial Cells in the Cochlea of the Inner Ear.

Authors:  Mitsuo P Sato; Taiga Higuchi; Fumiaki Nin; Genki Ogata; Seishiro Sawamura; Takamasa Yoshida; Takeru Ota; Karin Hori; Shizuo Komune; Satoru Uetsuka; Samuel Choi; Masatsugu Masuda; Takahisa Watabe; Sho Kanzaki; Kaoru Ogawa; Hidenori Inohara; Shuichi Sakamoto; Hirohide Takebayashi; Katsumi Doi; Kenji F Tanaka; Hiroshi Hibino
Journal:  Front Mol Neurosci       Date:  2017-09-21       Impact factor: 5.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.